Literature DB >> 26622611

Upregulation of SOX9 promotes cell proliferation, migration and invasion in lung adenocarcinoma.

Xiaoying Wang1, Ying Ju2, M I Zhou3, Xiaoli Liu3, Chengjun Zhou1.   

Abstract

Sex determining region Y-box 9 (SOX9) is an important transcription factor in development and has been implicated in several types of cancer. Although the association between upregulation of SOX9 and lung adenocarcinoma (ADC) has been reported previously, the role of SOX9 in the proliferation, migration and invasion of cancer cells remains unclear. Therefore, in the present study, SOX9 expression was detected in 163 human lung adenocarcinoma tissues by immunohistochemistry and western blotting. It was found that the SOX9 protein was over-expressed in the majority of lung adenocarcinoma. The full-length human SOX9 plasmid was then transfected into the lung ADC A549 cell line. An MTT assay was used to investigate the role of SOX9 in cell proliferation. Scratch and extracellular matrix cell invasion assays were performed to investigate whether SOX9 promotes the migration and invasion of lung ADC cells. The results revealed that ectopic overexpression of SOX9 in the lung adenocarcinoma cell line resulted in a marked increase in cell proliferation, migration and invasion. Accordingly, knockdown of SOX9 by RNA interference resulted in the inhibition of cell growth, migration and invasion. The present data indicate that SOX9 may act as a novel marker for lung adenocarcinoma and perform an important role in cell proliferation, migration and invasion.

Entities:  

Keywords:  SOX9; invasion; lung adenocarcinoma; migration; proliferation

Year:  2015        PMID: 26622611      PMCID: PMC4509053          DOI: 10.3892/ol.2015.3303

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  23 in total

1.  SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells.

Authors:  Patrick Müller; Justin D Crofts; Ben S Newman; Laura C Bridgewater; Chin-Yo Lin; Jan-Ake Gustafsson; Anders Ström
Journal:  Breast Cancer Res Treat       Date:  2009-03-26       Impact factor: 4.872

2.  Analysis of SOX9 expression in colorectal cancer.

Authors:  Bingjian Lü; Yihu Fang; Jing Xu; Lipei Wang; Fangying Xu; Enping Xu; Qiong Huang; Maode Lai
Journal:  Am J Clin Pathol       Date:  2008-12       Impact factor: 2.493

3.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

4.  Distribution according to histologic type and outcome by gender and age group in Taiwanese patients with lung carcinoma.

Authors:  Kuan-Yu Chen; Chia-Hsuin Chang; Chong-Jen Yu; Sow-Hsong Kuo; Pan-Chyr Yang
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

5.  Adenocarcinoma of the lung in young patients: the M. D. Anderson experience.

Authors:  N S Liu; M R Spitz; B L Kemp; C Cooksley; F V Fossella; J S Lee; W K Hong; F R Khuri
Journal:  Cancer       Date:  2000-04-15       Impact factor: 6.860

6.  Sox9 is required for prostate development.

Authors:  Martin K Thomsen; Christopher M Butler; Michael M Shen; Amanda Swain
Journal:  Dev Biol       Date:  2008-02-07       Impact factor: 3.582

7.  Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9.

Authors:  T Wagner; J Wirth; J Meyer; B Zabel; M Held; J Zimmer; J Pasantes; F D Bricarelli; J Keutel; E Hustert; U Wolf; N Tommerup; W Schempp; G Scherer
Journal:  Cell       Date:  1994-12-16       Impact factor: 41.582

8.  Novel SOX9 expression during human pancreas development correlates to abnormalities in Campomelic dysplasia.

Authors:  K Piper; S G Ball; J W Keeling; S Mansoor; D I Wilson; N A Hanley
Journal:  Mech Dev       Date:  2002-08       Impact factor: 1.882

Review 9.  Molecular pathology of lung cancer: current status and future directions.

Authors:  Mee Sook Roh
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-08-29

10.  SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes.

Authors:  Philippe Blache; Marc van de Wetering; Isabelle Duluc; Claire Domon; Philippe Berta; Jean-Noël Freund; Hans Clevers; Philippe Jay
Journal:  J Cell Biol       Date:  2004-07-05       Impact factor: 10.539

View more
  8 in total

1.  MicroRNA-216b regulated proliferation and invasion of non-small cell lung cancer by targeting SOX9.

Authors:  Sida Liu; Han Dong; Hui Dai; Danwei Liu; Zhihao Wang
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

2.  MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9.

Authors:  Yanwei Cui; Lei Zhao; Shilei Zhao; Tao Guo; Fengzhou Li; Zhuoshi Li; Lei Fang; Taihua Wu; Chundong Gu
Journal:  Hum Cell       Date:  2019-05-11       Impact factor: 4.174

3.  In vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction.

Authors:  Yingcai Hong; Huaisheng Chen; Zhanpeng Rao; Bin Peng; Hong Hu; Shaolin Lin; Zhenglei Xu
Journal:  Exp Ther Med       Date:  2018-01-12       Impact factor: 2.447

4.  Sox9 in mouse urogenital sinus epithelium mediates elongation of prostatic buds and expression of genes involved in epithelial cell migration.

Authors:  Andrew J Schneider; Joseph Gawdzik; Chad M Vezina; Tracie R Baker; Richard E Peterson
Journal:  Gene Expr Patterns       Date:  2019-10-25       Impact factor: 1.224

5.  SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.

Authors:  Georg Richtig; Ariane Aigelsreiter; Daniela Schwarzenbacher; Anna Lena Ress; Jan Basri Adiprasito; Verena Stiegelbauer; Gerald Hoefler; Silvia Schauer; Tobias Kiesslich; Peter Kornprat; Thomas Winder; Florian Eisner; Armin Gerger; Herbert Stoeger; Rudolf Stauber; Carolin Lackner; Martin Pichler
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

6.  Prognostic value of SOX9 in cervical cancer: Bioinformatics and experimental approaches.

Authors:  Huan Chen; Xupeng Chen; Fanhua Zeng; Aizhen Fu; Meiyuan Huang
Journal:  Front Genet       Date:  2022-08-08       Impact factor: 4.772

7.  Expression of Reg IV and SOX9 and their correlation in human gastric cancer.

Authors:  Na Zhang; Dandan Chai; Huifen Du; Kesheng Li; Wenguang Xie; Xingwen Li; Rong Yang; Xiaowen Lian; Yang Xu
Journal:  BMC Cancer       Date:  2018-03-27       Impact factor: 4.430

8.  Hypoxia Activates SOX5/Wnt/β-Catenin Signaling by Suppressing MiR-338-3p in Gastric Cancer.

Authors:  Jing-Jing Zheng; Qiao-Yan Que; Hong-Tao Xu; de-Sheng Luo; Zheng Sun; Jun-Sheng Ni; Hai-Feng Que; Ji Ma; Dan Wu; Hua Shi
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.